Delivery Order SPE2DR25D3110-SPE2DR26F8EC8
- Not listed
- The Defense Logistics Agency awarded a $18,637.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL) on September 25, 2025, with an ultimate completion date of September 26, 2025. The contract was not set-aside and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,848.26 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on September 4, 2025, with a completion date of September 5, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- AmerisourceBergen Drug Corp was awarded a $6,356.08 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on December 3, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) with an ultimate completion date of December 4, 2025. The award, which was competitively procured without a set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,272.62 for Ozempic 0.25-0.5 mg/dose pens (3mL) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,370.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) under contract number 4568429801. This non-competitive delivery order, awarded on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a supply of this diabetes medication to support federal healthcare needs. The contract was fulfilled by AmerisourceBergen's corporate office, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $36,663.92 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $10,422.94 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performance-based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,233.87 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $11,488.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a $5,574.45 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3mL) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D3110Indefinite Delivery Contract
- SPE2DR25D3110-SPE2DR26F8EC8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,848.59 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp leverages its comprehensive IDC vehicle to fulfill the Defense Health Agency's pharmaceutical supply requirements across therapeutic domains. This delivery order exemplifies the company's role in supporting military healthcare programs by providing brand-name medications essential for chronic disease management. The contract reflects the company's consistent capability to meet federal procurement standards through open competition and deliver specialized medical commodities to support DoD and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 12/8/25 |